---
figid: PMC11730190__tcr-13-12-7015-f4
figtitle: Action of DPEP1 in malignant tumors
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11730190
filename: tcr-13-12-7015-f4.jpg
figlink: /pmc/articles/PMC11730190/figure/F4/
number: F4
caption: Mechanism of action of DPEP1 in malignant tumors. DPEP1 inhibits the expression
  of GSK-3β by converting LTD4 and reduces the expression of β-catenin, thus affecting
  the expression of E-cadherin. DPEP1 activates the PI3K/AKT/mTOR signaling pathway,
  promoting tumor cell proliferation, invasion, and migration. c-Myc binds to the
  specific DNA motif and transcriptionally active DPEP1 expression, playing a role
  in regulating cell growth, apoptosis, and metabolism. ASCL2 can activate DPEP1 and
  reversely maintain the stability of ASCL2 by inhibiting its ubiquitination. TGF-β
  and EGFR can both inhibit the expression and function of DPEP1. Meanwhile, TGF-β
  can directly inhibit E-cadherin, promoting the invasion and migration of tumor cells.
  DPEP, dipeptidase; EGFR, epidermal growth factor receptor; GPI, glycosylphosphatidylinositol;
  LTD4, leukotriene D4; LTE4, leukotriene E4; TGF-β, transforming growth factor beta;
  GSK-3β, glycogen synthase kinase 3 beta; ASCL2, achaete scute complex-like 2; c-Myc,
  cellular Myc; mTOR, mechanistic target of rapamycin kinase
papertitle: 'Insight into dipeptidase 1: structure, function, and mechanism in gastrointestinal
  cancer diseases'
reftext: Lei Wang, et al. Transl Cancer Res. 2024 Dec 27;13(12).
year: '2024'
doi: 10.21037/tcr-2024-2436
journal_title: Translational Cancer Research
journal_nlm_ta: Transl Cancer Res
publisher_name: AME Publications
keywords: Dipeptidase 1 (DPEP1) | cancer disease | structure | function | mechanism
automl_pathway: 0.9332092
figid_alias: PMC11730190__F4
figtype: Figure
redirect_from: /figures/PMC11730190__F4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11730190__tcr-13-12-7015-f4.html
  '@type': Dataset
  description: Mechanism of action of DPEP1 in malignant tumors. DPEP1 inhibits the
    expression of GSK-3β by converting LTD4 and reduces the expression of β-catenin,
    thus affecting the expression of E-cadherin. DPEP1 activates the PI3K/AKT/mTOR
    signaling pathway, promoting tumor cell proliferation, invasion, and migration.
    c-Myc binds to the specific DNA motif and transcriptionally active DPEP1 expression,
    playing a role in regulating cell growth, apoptosis, and metabolism. ASCL2 can
    activate DPEP1 and reversely maintain the stability of ASCL2 by inhibiting its
    ubiquitination. TGF-β and EGFR can both inhibit the expression and function of
    DPEP1. Meanwhile, TGF-β can directly inhibit E-cadherin, promoting the invasion
    and migration of tumor cells. DPEP, dipeptidase; EGFR, epidermal growth factor
    receptor; GPI, glycosylphosphatidylinositol; LTD4, leukotriene D4; LTE4, leukotriene
    E4; TGF-β, transforming growth factor beta; GSK-3β, glycogen synthase kinase 3
    beta; ASCL2, achaete scute complex-like 2; c-Myc, cellular Myc; mTOR, mechanistic
    target of rapamycin kinase
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - EGFR
  - GPI
  - GNPDA1
  - ASCL2
  - DPEP1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - TGFB1
  - TGFB2
  - TGFB3
  - CDH1
  - FZR1
  - AKT1
  - AKT2
  - AKT3
  - GSK3A
  - GSK3B
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - MYC
  - MTOR
  - LTD4
  - LTE4
---
